Apellis Pharmaceuticals Inc (APLS) Insider Trading

Total insider buys:
  • $23,844,337.28
Total insider sells:
  • $103,599,594.95
Most recent insider trade:
  • Sept. 16, 2024
Most active insider trader:
  • Alec Machiels
Trader NameDateTitleAmountPriceTypeTotal Value
April 14, 2021Insider500$42.82Sell$21,410.00
April 1, 2021Insider600$43.41Sell$26,046.00
March 15, 2021Insider500$46.77Sell$23,385.00
March 15, 2021Director2,500$46.77Sell$116,925.00
March 10, 2021Insider6,250$50.74Sell$317,125.00
March 5, 2021Insider5,000$48.62Sell$243,100.00
Feb. 9, 2021VP2,000$50.00Sell$100,000.00
Jan. 15, 2021Director2,500$53.15Sell$132,875.00
Jan. 14, 2021Insider4,000$51.99Sell$207,960.00
Dec. 15, 2020CEO5,000$52.16Sell$260,800.00
Dec. 14, 2020Director25,000$54.67Sell$1,366,750.00
Dec. 14, 2020General Counsel18,333$50.94Sell$933,883.02
Dec. 7, 2020Director25,000$50.59Sell$1,264,750.00
Dec. 4, 2020Director6,436$50.26Sell$323,473.36
Dec. 4, 2020VP18,000$50.00Sell$900,000.00
Dec. 1, 2020Insider600$48.25Sell$28,950.00
Nov. 16, 2020Director2,500$39.38Sell$98,450.00
Nov. 16, 2020CEO5,000$39.38Sell$196,900.00
Nov. 2, 2020Insider600$31.09Sell$18,654.00
Oct. 15, 2020Director2,500$35.00Sell$87,500.00
Oct. 15, 2020CEO5,000$34.46Sell$172,300.00
Oct. 7, 2020Director7,500$35.00Sell$262,500.00
Oct. 7, 2020Insider12,000$35.00Sell$420,000.00
Sept. 15, 2020CEO5,000$30.96Sell$154,800.00
Sept. 1, 2020Insider600$31.58Sell$18,948.00
Aug. 20, 2020CEO3,457$30.00Sell$103,710.00
Aug. 18, 2020CEO1,543$30.00Sell$46,290.00
Aug. 3, 2020Insider600$26.28Sell$15,768.00
July 15, 2020CEO5,000$32.12Sell$160,600.00
July 1, 2020Insider850$32.43Sell$27,565.50
June 15, 2020Director2,500$30.21Sell$75,525.00
June 15, 2020CEO5,000$30.21Sell$151,050.00
Nov. 15, 2019CEO5,000$27.82Sell$139,100.00
Oct. 15, 2019CEO5,000$27.81Sell$139,050.00
Sept. 24, 2019COO42,460$24.82Sell$1,053,857.20
Sept. 16, 2019CEO5,000$26.59Sell$132,950.00
Aug. 29, 2019CFO11,699$29.71Buy$347,577.29
Aug. 15, 2019CEO10,000$26.80Sell$268,000.00
March 11, 2019Major Shareholder441,176$17.00Buy$7,499,992.00
Sept. 21, 2018Major Shareholder81,323$19.48Buy$1,584,172.04
Sept. 19, 2018Major Shareholder140,000$18.34Buy$2,567,600.00
Sept. 14, 2018General Counsel15,776$18.78Sell$296,273.28
May 24, 2018Insider2,935$20.37Buy$59,785.95
Nov. 13, 2017Major Shareholder127,515$14.00Buy$1,785,210.00
First«4 of 4»Last
  • Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.

  • The insider traders at Apellis Pharmaceuticals Inc are: Alec Machiels, Federico Grossi, Cedric Francois, Pascal Deschatelets, A. Sinclair Dunlop, Mark Jeffrey Delong, David O Watson, Adam J Townsend, Lukas Scheibler, Timothy Eugene Sullivan, Nicole D Perry, James George Chopas, Jeffrey Eisele, Morningside Venture Investment, Karen Lewis, Nur Nicholson, Global Strategic Fund I Venbio, Victoria L. Brown, Deschatelets Pascal, Caroline Baumal, Victoria L Brown, and Machiels Alec

  • The most active insider trader at Apellis Pharmaceuticals Inc is Alec Machiels with 30 trades.

  • Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $50,716,137.07.

  • Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.

  • The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 16, 2024.

  • The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.

  • The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.